Marrazzo Jeffrey D

Marrazzo Jeffrey D is listed in filings as Director at Prime Medicine, Inc.. This profile follows SEC Form 4 activity through Aug 5, 2025, including 9 public disclosures. Recent filings connect the profile to Prime Medicine, Inc. (PRME). The current snapshot covers public activity from Jun 14, 2024 to Aug 5, 2025. Reported amounts are shown as $345.6K to $72.6K. The page organizes purchases, sales, issuer links, reported share activity, and filing evidence for review as public disclosure data.